In this edition of the Moneycontrol's Explained series, find out if the vaccine is worth the hype.
Earlier this week, the Massachusetts-based Moderna announced positive interim phase-1 or early-stage clinical trial data. Moderna's market valuation soared to $29 billion.
The Food and Drug Administration (FDA) has approved the mRNA vaccine for phase-II trials.
In this edition of the Moneycontrol's Explained series, find out if the vaccine is worth the hype.
Watch the video for more.
Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
First Published on May 22, 2020 12:50 pm
